Variant report
Variant | esv2763476 |
---|---|
Chromosome Location | chr5:101298861-101303484 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529285022 | chr5:101300800-101300801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6886984 | chr5:101300824-101300825 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs368870282 | chr5:101300891-101300892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566091747 | chr5:101300914-101300915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539916267 | chr5:101300917-101300918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184376924 | chr5:101300972-101300973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562529150 | chr5:101301010-101301011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551535434 | chr5:101301011-101301012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569851369 | chr5:101301012-101301013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371298527 | chr5:101301056-101301057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537207411 | chr5:101301084-101301085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189989161 | chr5:101301102-101301103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35435657 | chr5:101301130-101301131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34937259 | chr5:101301142-101301143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192851554 | chr5:101301170-101301171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144543429 | chr5:101301191-101301192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10688189 | chr5:101301192-101301193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs67106500 | chr5:101301193-101301194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10655237 | chr5:101301194-101301195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184831484 | chr5:101301221-101301222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116281864 | chr5:101301240-101301241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552924313 | chr5:101301267-101301268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149871651 | chr5:101301293-101301294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545092095 | chr5:101301301-101301302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563209753 | chr5:101301317-101301318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115147193 | chr5:101301359-101301360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563511721 | chr5:101301395-101301396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs899045 | chr5:101301416-101301417 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs76372458 | chr5:101301419-101301420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78305184 | chr5:101301429-101301430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540899531 | chr5:101301442-101301443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144950405 | chr5:101301470-101301471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550805256 | chr5:101301484-101301485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559708551 | chr5:101301524-101301525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533143280 | chr5:101301528-101301529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10039885 | chr5:101301545-101301546 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs370895722 | chr5:101301561-101301562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570033399 | chr5:101301582-101301583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56111034 | chr5:101301597-101301598 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs149048516 | chr5:101301609-101301610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143075012 | chr5:101301648-101301649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534925788 | chr5:101301713-101301714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552945838 | chr5:101301744-101301745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372178301 | chr5:101301745-101301746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577588424 | chr5:101301754-101301755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139292992 | chr5:101301766-101301767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532787528 | chr5:101301776-101301777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11749954 | chr5:101301778-101301779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552779051 | chr5:101301786-101301787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546706381 | chr5:101301834-101301835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101300800-101303000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr5:101302000-101302800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr5:101302200-101302600 | Enhancers | Brain Germinal Matrix | brain |
4 | chr5:101302200-101302800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr5:101302400-101302800 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr5:101303000-101305400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |